Reverse myocardial effects of intermedin in pressure-overloaded hearts: Role of endothelial nitric oxide synthase activity

Journal of Physiology

Volumn 591, Issue 3, 2013, Pages 677-687

  Pires, Ana Luísa ^a   Pinho, Marta ^a   Alves, Bárbara Silvana ^a   Pinho, Sónia ^a   Sena, Cristina ^b   Seica, Raquel Maria ^b   Leite Moreira, Adelino F ^a  

^a University of Porto   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERMEDIN; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PEROXYNITRITE; PHOSPHOLAMBAN; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CARDIOVASCULAR RESPONSE; CHRONIC DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE RELAXATION; HEART PAPILLARY MUSCLE; HORMONE ACTION; MALE; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

ADRENOMEDULLIN; ANIMALS; BLOOD PRESSURE; ENZYME INHIBITORS; HEMODYNAMICS; MALE; MUSCLE RELAXATION; MYOCARDIAL CONTRACTION; NEUROPEPTIDES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; PAPILLARY MUSCLES; RATS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION;

EID: 84873145657     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.240812     Document Type: Article

References (26)

1. Bauer PM, Fulton D, Boo YC, Sorescu GP, Kemp BE, Jo H & Sessa WC (2003). Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J Biol Chem 278, 14841-14849.
2. Bell D, Campbell M, Wang X, Earle JA, Cosby SL & McDermott BJ (2010). Adrenomedullin gene delivery is cardio-protective in a model of chronic nitric oxide deficiency combining pressure overload, oxidative stress and cardiomyocyte hypertrophy. Cell Physiol Biochem 26, 383-394.
3. Bell D, Zhao Y, McCoy FP, Devine A & McDermott BJ (2008). Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes. Cell Physiol Biochem 21, 409-420.
4. 16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to β-agonists. J Biol Chem 275, 38938-38943.
5. Dong F, Taylor MM, Samson WK & Ren J (2006). Intermedin (adrenomedullin-2) enhances cardiac contractile function via a protein kinase C- and protein kinase A-dependent pathway in murine ventricular myocytes. J Appl Physiol 101, 778-784.
6. Fontes-Sousa AP, Pires AL, Carneiro CS, Bras-Silva C & Leite-Moreira AF (2009). Effects of adrenomedullin on systolic and diastolic myocardial function. Peptides 30, 796-802.
7. Hirose T, Totsune K, Mori N, Morimoto R, Hashimoto M, Nakashige Y, Metoki H, Asayama K, Kikuya M, Ohkubo T, Hashimoto J, Sasano H, Kohzuki M, Takahashi K & Imai Y (2008). Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure. Eur J Heart Fail 10, 840-849.
8. Kandilci HB, Gumusel B & Lippton H (2008). Intermedin/adrenomedullin-2 (IMD/AM2) relaxes rat main pulmonary arterial rings via cGMP-dependent pathway: role of nitric oxide and large conductance calcium-activated potassium channels (BK(Ca)). Peptides 29, 1321-1328.
9. Kato K, Yin H, Agata J, Yoshida H, Chao L & Chao J (2003). Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am J Physiol Heart Circ Physiol 285, H1506-1514.
10. Kojda G & Kottenberg K (1999). Regulation of basal myocardial function by NO. Cardiovasc Res 41, 514-523.
11. Moens AL, Leyton-Mange JS, Niu X, Yang R, Cingolani O, Arkenbout EK, Champion HC, Bedja D, Gabrielson KL, Chen J, Xia Y, Hale AB, Channon KM, Halushka MK, Barker N, Wuyts FL, Kaminski PM, Wolin MS, Kass DA & Barouch LA (2009). Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the β3-adrenoreceptor. J Mol Cell Cardiol 47, 576-585.
12. Moens AL, Takimoto E, Tocchetti CG, Chakir K, Bedja D, Cormaci G, Ketner EA, Majmudar M, Gabrielson K, Halushka MK, Mitchell JB, Biswal S, Channon KM, Wolin MS, Alp NJ, Paolocci N, Champion HC & Kass DA (2008). Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 117, 2626-2636.
13. Mohan P, Brutsaert DL & Sys SU (1995). Myocardial performance is modulated by interaction of cardiac endothelium derived nitric oxide and prostaglandins. Cardiovasc Res 29, 637-640.
14. Mount PF, Kemp BE & Power DA (2007). Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol 42, 271-279.
15. 1-47 does not improve functional recovery in postischemic hearts. Naunyn Schmiedebergs Arch Pharmacol 384, 535-542.
16. Pan CS, Yang JH, Cai DY, Zhao J, Gerns H, Yang J, Chang JK, Tang CS & Qi YF (2005). Cardiovascular effects of newly discovered peptide intermedin/adrenomedullin 2. Peptides 26, 1640-1646.
17. Pires AL, Pinho M, Sena CM, Seica RM & Leite-Moreira AF (2012). Intermedin elicits a negative inotropic effect in rat papillary muscles mediated by endothelial derived nitric oxide. Am J Physiol Heart Circ Physiol 302, H1131-1137.
18. Roh J, Chang CL, Bhalla A, Klein C & Hsu SY (2004). Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 279, 7264-7274.
19. Shah AM & MacCarthy PA (2000). Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86, 49-86.
20. Takei Y, Inoue K, Ogoshi M, Kawahara T, Bannai H & Miyano S (2004). Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett 556, 53-58.
21. Takimoto E, Champion HC, Li M, Ren S, Rodriguez ER, Tavazzi B, Lazzarino G, Paolocci N, Gabrielson KL, Wang Y & Kass DA (2005). Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest 115, 1221-1231.
22. Thony B, Auerbach G & Blau N (2000). Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347, 1-16.
23. 1-53 inhibits rat cardiac fibroblast activation induced by angiotensin II. Regul Pept 158, 19-25.
24. Yang JH, Qi YF, Jia YX, Pan CS, Zhao J, Yang J, Chang JK & Tang CS (2005). Protective effects of intermedin/adrenomedullin2 on ischemia/reperfusion injury in isolated rat hearts. Peptides 26, 501-507.
25. Zhang HY, Jiang W, Liu JY, Li Y, Chen CL, Xin HB & Huang DJ (2009). Intermedin is upregulated and has protective roles in a mouse ischemia/reperfusion model. Hypertens Res 32, 861-868.
26. Zhao Y, Bell D, Smith LR, Zhao L, Devine AB, McHenry EM, Nicholls DP & McDermott BJ (2006). Differential expression of components of the cardiomyocyte adrenomedullin/ intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. J Pharmacol Exp Ther 316, 1269-1281.